Secondary Progressive Multiple Sclerosis

CME

Video

Expert Insights on COVID-19 Prophylaxis in Patients With Multiple Sclerosis and Related Disorders

1.50 CME

1.50 NCPD

90 MINS

$0 FEE

Clinical Guidance

Multiple Sclerosis

Assessment and Treatment

Assessment of Multiple Sclerosis

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Multiple Sclerosis

Assessment and Treatment

Treatment Options

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Multiple Sclerosis

Overview

Pathophysiology

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Multiple Sclerosis

Overview

Etiology and Risk Factors

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

Clinical Guidance

Multiple Sclerosis

Overview

Definition and Classification

Pavan Bhargava, MD

Free clinical reference tool that includes treatment options; diagnosis information; guidelines; and more.

CME

Video

Overcoming Obstacles to Optimal Multiple Sclerosis (MS) Care in Minority Patient Populations

0.75 CME

0.75 CNE

45 MINS

$0 FEE

CME

Ace the Case

Ace the Case: A 52-Year-Old Woman With Gradual Walking Difficulties

0.25 CME

0.25 CNE

15 MINS

$0 FEE

CME

Ace the Case

Ace the Case: A 32-Year-Old Woman With Aphasia and Hemiparesis

0.25 CME

0.25 CNE

15 MINS

$0 FEE

News

July 06, 2021

2 min read

Save

High-efficacy therapy 'superior' in reducing relapses, but not delaying disability, in MS

Patients with active secondary progressive MS who received high-efficacy therapy experienced relapses less often than those on low-efficacy therapy, according to findings published in Neurology.